Etomidate Injection shortage
Current 18 presentations · 6 manufacturers · first FDA posting Oct 5, 2022 · last update Oct 14, 2026
Manufacturers: Caplin Steriles, Ltd., Eugia US LLC, Gland Pharma Limited, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company, Mylan Institutional, a Viatris Company
Stated reasons (per FDA): Demand increase for the drug; Other
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Etomidate, Injection, 2mg/1 mL (NDC 65219-445-10) | Caplin Steriles, Ltd. | Current Available |
— | Check wholesalers for inventory; Marketed by Fresenius Kabi | Posted Oct 5, 2022 Updated Jun 16, 2026 |
| Etomidate, Injection, 2mg/mL (NDC 65219-447-20) | Caplin Steriles, Ltd. | Current Available |
— | Check wholesalers for inventory; Marketed by Fresenius Kabi | Posted Oct 5, 2022 Updated Jun 16, 2026 |
| Etomidate, Injection, 2 mg/mL (NDC 72485-508-10) | Caplin Steriles, Ltd. | Current Available |
— | Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586 | Posted Oct 5, 2022 Updated Jun 16, 2026 |
| Etomidate, Injection, 2 mg/mL (NDC 72485-509-10) | Caplin Steriles, Ltd. | Current Available |
— | Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586 | Posted Oct 5, 2022 Updated Jun 16, 2026 |
| Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: TBD. Check wholesalers for inventory | Posted Oct 5, 2022 Updated Oct 2, 2026 |
| Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: TBD. Check wholesalers for inventory | Posted Oct 5, 2022 Updated Oct 2, 2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10) | Gland Pharma Limited | Current Available |
— | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | Posted Oct 5, 2022 Updated Jul 22, 2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10) | Gland Pharma Limited | Current Available |
— | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | Posted Oct 5, 2022 Updated Jul 22, 2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Novaplus label | Posted Oct 5, 2022 Updated Oct 14, 2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Novaplus label | Posted Oct 5, 2022 Updated Oct 14, 2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional product will be made available as it is released. | Posted Oct 5, 2022 Updated Oct 14, 2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional product will be made available as it is released. | Posted Oct 5, 2022 Updated Oct 14, 2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Distributed by Civica | Posted Oct 5, 2022 Updated Oct 14, 2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Distributed by Civica | Posted Oct 5, 2022 Updated Oct 14, 2026 |
| Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Oct 5, 2022 Updated Oct 8, 2026 | |
| Amidate, Injection, 2 mg/mL (NDC 0409-6695-02) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Other | Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Posted Oct 5, 2022 Updated Oct 8, 2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10) | Mylan Institutional, a Viatris Company | Current Unavailable |
Demand increase for the drug | Estimated recovery: November 2026 | Posted Oct 5, 2022 Updated Oct 5, 2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted Oct 5, 2022 Updated Oct 5, 2026 |